Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    Ava to commence trial of fertility tracker device for Covid-19 detection

    Ava, a digital healthcare company that focuses on women's reproductive health, has announced it will be launching the first study of its...

    Insulet’s Omnipod 5 trial shows benefits across patient groups with Type 1 diabetes

    Clinical trial results for Insulet's Omnipod 5 automated insulin pump system showed improvements across multiple metrics after three months of use for adult, adolescent...

    Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

    Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan® , the first and only patient-friendly, preparation-free, screening test to...

    BrainQ announces encouraging study results for new therapy to reduce disability after stroke

    Study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin...

    Abbott halts heart pump trial

    Abbott (NYSE:ABT) has halted a clinical trial comparing its HeartMate II ventricular assist device with the Abiomed (NSDQ:ABMD)  Impella heart pumps.

    First of several Clinical Studies showing Benefits of BandGrip

    New research published in the February issue of Journal of Wound Care (JWC) concludes the unique micro-anchor skin closure device known as BandGrip is more...

    ZygoFix Completes $2 Million Round and Launches Clinical Study

    ZygoFix completed a $2 million round. Funds will support further clinical studies, enhancements to the company's implant and tools, and regulatory clearance.

    First U.S. Patient Treated With BAGUERA®C Cervical Disc Prosthesis

    Spineart USA Inc. announced that clinical principal investigator, Dr. Domagoj Coric at Carolina Neurosurgery and Spine Associates in Charlotte NC, performed the first surgery in the two-level...

    Virta Health touts a study of treatment preventing progression to Type 2 diabetes

    Virta Health announced today that a study of its diabetes progression prevention treatment proved more effective than initially expected.

    Latest articles

    Neuromodulation treatment for chronic migraine given CE mark

    Chordate Medical Holding AB, a Swedish medtech company, has developed and patented an innovative treatment method: K.O.S. The company's existing EC-certificate for...

    Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M

    While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19, one of...

    Endologix LLC Announces Launch of Alto Abdominal Stent Graft System in Canada and Argentina

    Endologix LLC today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. ALTO was...

    Bose Officially Introduces SoundControl Hearing Aids

    First FDA-Cleared Direct-to-Consumer Hearing Aid Revolutionary Bose App Clinically Proven for Audiologist-Quality Results.